Monday, March 30, 2020

Lupin gets EIR from USFDA for Florida-based inhalation research centre

Lupin gets EIR from USFDA for Florida-based inhalation research centre The facility was inspected by the US Food and Drug Administration (USFDA), between February 19, 2020, and February 26, 2020, on behalf of the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) for company#39;s application for generic Fostair.

from Moneycontrol Business News https://ift.tt/2QXj1V7
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...